MedTech Spectrum

Article Name Predictive Diagnostics

Elucid to Showcase FDA-Cleared PlaqueIQ™ Platform at SCCT 2025

Breakthrough AI-Powered Software Delivers Histology-Based Plaque Analysis for Personalized Cardiac Care

11th July, 2025

Veriphi Launches Groundbreaking IV Drug Verification System at St Vincent’s, Pioneering Safer Oncology Compounding

World-first deployment of AI-powered laser tech enhances medication safety in high-risk hospital settings

10th July, 2025

SimBioSys Earns Third FDA Clearance for TumorSight™ Viz

AI-Powered 3D Surgical Planning Tool Advances Precision Breast Cancer Surgery with Latest Regulatory Milestone

10th July, 2025

Mann Eye Institute Unveils Pioneering Treatment for Dry AMD

New Therapeutic Breakthrough Offers Hope for Patients with Geographic Atrophy, the Advanced Form of Dry Age-Related Macular Degeneration

10th July, 2025

Medtronic Treats First Patient in SPYRAL GEMINI Multi-Organ Pilot Study

Study to Evaluate Renal Denervation Therapy’s Potential Benefits Beyond Hypertension Across Multiple Organ Systems

10th July, 2025

Cerapedics Treats First U.S. Patient with PearlMatrix™ Following FDA Approval

Milestone Marks Commercial Launch of P-15 Peptide-Enhanced Bone Graft for Use in Spinal Fusion Procedures

09th July, 2025

MediView Launches Multicenter Study to Validate XR90™ Extended Reality Surgical Navigation

Study to Evaluate Accuracy and Clinical Impact of XR-Guided Soft Tissue Biopsy Across Leading U.S. Medical Centers

09th July, 2025

Companion Spine to Acquire Paradigm Spine GmbH and Coflex®, CoFix® Implant Assets from Xtant Medical

Strategic Acquisition Expands Companion Spine’s Portfolio in Motion-Preserving, Minimally Invasive Spine Therapies

09th July, 2025

Rain Eye Drops Launches First-Ever Dispenser Aid for Single-Use Eye Drops

Innovative Device Enhances Ease, Precision, and Accessibility for Patients Using Preservative-Free Eye Medications

09th July, 2025

Eko CORE 500® Wins Red Dot Design Award for Product Innovation

Next-Generation Digital Stethoscope Recognized for Excellence in Design, Usability, and Clinical Impact

09th July, 2025

Cochlear Unveils World’s First Smart Cochlear Implant System

Revolutionary Implant Integrates Sensor-Driven Technology and Cloud Connectivity to Enhance Hearing Outcomes and Patient Monitoring

09th July, 2025

JenaValve Showcases Live Trilogy™ THV Implant Procedures at New York Valves 2025

Breakthrough transcatheter aortic valve technology for aortic regurgitation and stenosis featured in front of global clinical audience during premier interventional cardiology event.

08th July, 2025

MicroGenDX Revolutionizes Infectious Disease Detection with 24-Hour NGS Testing Platform

Pioneering next-generation sequencing technology delivers rapid, accurate pathogen identification to accelerate targeted treatment and improve patient outcomes across clinical settings.

08th July, 2025

Boston Scientific Secures FDA Approval for Expanded Labeling of FARAPULSE™ PFA System

Milestone enhances clinical use of the FARAPULSE™ Pulsed Field Ablation platform for treatment of atrial fibrillation, strengthening its role in next-generation cardiac electrophysiology.

08th July, 2025

Alcon to Acquire LumiThera, Expanding Retinal Portfolio with Breakthrough AMD Therapy

Acquisition adds FDA-cleared Valeda® Light Delivery System to Alcon’s pipeline, targeting early and intermediate dry age-related macular degeneration through photobiomodulation technology

08th July, 2025

Lifeforce and Toku Partner to Revolutionize Preventive Health with AI-Driven Retinal Scans

Integration of Toku’s retinal imaging technology with Lifeforce’s longevity medicine platform aims to slow aging and reduce cardiovascular risk through early, personalized insights.

08th July, 2025

Morphic Medical Secures CE Mark for RESET® Endoscopic Therapy Device

Regulatory milestone paves the way for expanded access to Morphic’s non-implant, incisionless solution for treating acid reflux and related gastrointestinal disorders across Europe.

08th July, 2025

BioNxt Advances Sublingual Cladribine Program Toward Next Phase for MS Treatment

Innovative thin-film formulation of cladribine moves forward as BioNxt prepares for next-stage development in multiple sclerosis therapy, aiming to enhance patient convenience and treatment adherence.

07th July, 2025